{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"ss-31-glp1-gut","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/ss-31-glp1-gut/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"ss-31-glp1-gut","title":"SS-31 (Elamipretide) for GLP-1 Agonist Gut Damage: Mitochondrial Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:03.812Z","body_excerpt":"## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 agonists slow gastric emptying as part of their metabolic action. In some people this effect becomes excessive and leads to symptoms of gastroparesis. The stomach and small intestine rely on smooth muscle cells and enteric neurons that need steady ATP from mitochondria to contract and coordinate movement. When mitochondria in these cells produce excess reactive oxygen species or lose efficient electron transport, energy drops and motility slows further. Oxidative damage to cardiolipin in the inner mitochondrial membrane can worsen cristae structure and ATP output. If your GLP-1 use coincides with persistent delayed emptying, one layer of the problem may be mitochondrial stress in gut tissue rather than only the drug's direct receptor effect. Repair pathways that target this mitochondrial layer differ from simply stopping the drug or masking symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in enteric smooth muscle or neurons is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair at the cardiolipin level inside mitochondria — not because it masks slowed emptying.\n\nSS-31 binds directly to cardiolipin in the inner mitochondrial membrane. This interaction stabilizes cristae structure and supports electron transport chain efficiency. When cardiolipin is protected, electron leak drops and reactive oxygen species production falls. Cells regain better ATP output without the drug needing to act on GLP-1 receptors themselves. In gut tissue where mitochondria are strained, restoring this layer could support the energy needed for normal motility once the primary drug effect is addressed. The compound does not reduce gastric emptying on its own; it addresses a downstream cellular energy layer that may be compromised.\n\n## Why GLP-1 agonists (class) matters for you\n\n**Drug:** GLP-1 agonists (class)\n**What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\n**Therefore for you:** This drug suppresses a signal for gastric emptying to support blood sugar control and appetite reduction. That suppression helps metabolism but trades off against normal gut motility repair for some users by prolonging delayed emptying.\n\nGLP-1 receptor activation slows stomach emptying to limit post-meal glucose spikes. Observational data link the class to higher reported rates of gastroparesis diagnoses compared with other weight-loss drugs. The effect is dose- and duration-dependent in many cases. When emptying remains delayed for weeks or months, the mechanical and cellular stress on gut mitochondria may increase. Addressing only the mitochondrial layer with another compound does not reverse the receptor-mediated slowing; the two actions operate on different pathways.\n\n## How these fit together\n\nSingle-compound focus — SS-31 targets the mitochondrial layer while GLP-1 agonists act on receptor signaling that slows emptying. SS-31 (Elamipretide) addresses mitochondrial cardiolipin stabilization and ATP support. The GLP-1 drug supplies the metabolic signal change but can extend the period of low motility that stresses gut cell mitochondria. The two do not directly interact; one works on cellular energy machinery while the other modulates hormone signaling. If mitochondrial damage accumulates during prolonged GLP-1 use, the mitochondrial repair compound may complement management by supporting the energy layer without altering the primary drug mechanism.\n\n## What the evidence actually shows\n\nHuman data on SS-31 come from trials in primary mitochondrial myopathy and heart failure. One randomized trial in primary mitochondrial myopathy showed dose-dependent improvement in six-minute walk distance after five days of intravenous dosing (Class I evidence). Phase 2 and ","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c4","text":"No human trials have tested SS-31 in gastroparesis or GLP-1 gut damage.","tier":"human","weight":0.8,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific cross.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c1","text":"SS-31 binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae and reducing ROS production.","tier":"mechanistic","weight":0.3,"section":"Why SS-31 (Elamipretide) might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s9","s10"],"source_status":"sourced","why_material":"Establishes core mechanism relevant to mitochondrial repair layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c2","text":"One randomized trial showed dose-dependent improvement in 6-minute walk distance in primary mitochondrial myopathy patients after 5 days of elamipretide.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s28"],"source_status":"sourced","why_material":"Only Class I human efficacy data for SS-31.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"GLP-1 agonist use was associated with adjusted HR 3.67 for gastroparesis versus comparator in an observational study.","tier":"human","weight":0.8,"section":"Why GLP-1 agonists (class) matters for you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Quantifies increased risk of the condition in humans.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c5","text":"SS-31 improved mitochondrial function in ex vivo failing human hearts and in rodent models of oxidative stress.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s12","s16"],"source_status":"sourced","why_material":"Shows human tissue and animal data supporting mitochondrial effects.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s3","type":"pubmed","url":"https://jamanetwork.com/journals/jama/fullarticle/2810542","title":"GLP-1 Agonists and Gastrointestinal Adverse Events","quote":"Use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of ... gastroparesis (HR, 3.67 [95% CI, 1.15-11.90])","summary":"Observational study on GI risks including gastroparesis with GLP-1 agonists.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"bbdb283448a72ccc301e772a0ae07f03337793b162ee09d6f7a7d3bd5bb2ac8d"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11816484/","title":"Elamipretide: A Review of Its Structure, Mechanism of Action ...","quote":"The stabilization of cardiolipin by Elamipretide results in improved mitochondrial function, reduced oxidative stress, and mitigated cell damage","summary":"Review of SS-31 mechanism via cardiolipin binding.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"48d133bdff37d87424017ac50b9633961ac4ca6a3c5dca131f175ef75bd80111"},{"id":"s10","type":"review","url":"https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/elamipretide","title":"Elamipretide - an overview","quote":"Elamipretide ... selectively binds cardiolipin ... leading to reduced mitochondrial reactive oxygen species (ROS) generation and improved ATP production.","summary":"Overview confirming mitochondrial targeting.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"2657acdc0fd2ee0d3c4bf6a216bace2e7a565ec16150b9b197f0c2956c409364"},{"id":"s12","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 (also known as Elamipretide®...) Cognitive Vitality For Researchers","quote":"In an ex vivo study of failing human hearts, SS-31 treatment improved mitochondrial function","summary":"Summary of human tissue and preclinical data.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"9295f708b80697d18508908c59e36da569f1fd40152a93b74017707ee2145bf4"},{"id":"s16","type":"pubmed","url":"https://elifesciences.org/articles/55513","title":"Late-life restoration of mitochondrial function reverses ...","quote":"We show here that 8-week treatment of old mice with ... SS-31 ... can substantially reverse this deficit.","summary":"Rodent study on mitochondrial restoration in aging heart.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"d37452a29a02b5859b2b3d6db8acd802e196ff1fad435a37dcae27994f92eb17"},{"id":"s28","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"Participants who received the highest dose of elamipretide walked a mean of 64.5 m farther at day 5 compared to a change of 20.4 m in the placebo group","summary":"Human trial showing functional improvement in PMM.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"9885394fe8e86157863020808ed7c0519f2e4cb0bcdb4982e7ac57f090bc91a5"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s3","type":"pubmed","url":"https://jamanetwork.com/journals/jama/fullarticle/2810542","title":"GLP-1 Agonists and Gastrointestinal Adverse Events","quote":"Use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of ... gastroparesis (HR, 3.67 [95% CI, 1.15-11.90])","summary":"Observational study on GI risks including gastroparesis with GLP-1 agonists.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"bbdb283448a72ccc301e772a0ae07f03337793b162ee09d6f7a7d3bd5bb2ac8d"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11816484/","title":"Elamipretide: A Review of Its Structure, Mechanism of Action ...","quote":"The stabilization of cardiolipin by Elamipretide results in improved mitochondrial function, reduced oxidative stress, and mitigated cell damage","summary":"Review of SS-31 mechanism via cardiolipin binding.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"48d133bdff37d87424017ac50b9633961ac4ca6a3c5dca131f175ef75bd80111"},{"id":"s10","type":"review","url":"https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/elamipretide","title":"Elamipretide - an overview","quote":"Elamipretide ... selectively binds cardiolipin ... leading to reduced mitochondrial reactive oxygen species (ROS) generation and improved ATP production.","summary":"Overview confirming mitochondrial targeting.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"2657acdc0fd2ee0d3c4bf6a216bace2e7a565ec16150b9b197f0c2956c409364"},{"id":"s12","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 (also known as Elamipretide®...) Cognitive Vitality For Researchers","quote":"In an ex vivo study of failing human hearts, SS-31 treatment improved mitochondrial function","summary":"Summary of human tissue and preclinical data.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"9295f708b80697d18508908c59e36da569f1fd40152a93b74017707ee2145bf4"},{"id":"s16","type":"pubmed","url":"https://elifesciences.org/articles/55513","title":"Late-life restoration of mitochondrial function reverses ...","quote":"We show here that 8-week treatment of old mice with ... SS-31 ... can substantially reverse this deficit.","summary":"Rodent study on mitochondrial restoration in aging heart.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"d37452a29a02b5859b2b3d6db8acd802e196ff1fad435a37dcae27994f92eb17"},{"id":"s28","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"Participants who received the highest dose of elamipretide walked a mean of 64.5 m farther at day 5 compared to a change of 20.4 m in the placebo group","summary":"Human trial showing functional improvement in PMM.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"9885394fe8e86157863020808ed7c0519f2e4cb0bcdb4982e7ac57f090bc91a5"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"ss-31-glp1-gut","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":5,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":5,"claims_total":5,"sources":6,"anecdotal":0,"scientific":6,"user_reports":0,"questions":0,"evidence_ingests":0}}